Oppenheimer Upgrades Integer (NYSE:ITGR) to “Outperform”

Integer (NYSE:ITGR) was upgraded by investment analysts at Oppenheimer from a “market perform” rating to an “outperform” rating in a report released on Wednesday, Marketbeat Ratings reports. The brokerage presently has a $115.00 target price on the medical equipment provider’s stock. Oppenheimer’s price objective would indicate a potential upside of 35.06% from the company’s current price.

A number of other research firms also recently commented on ITGR. Zacks Research downgraded shares of Integer from a “hold” rating to a “strong sell” rating in a report on Monday. Wells Fargo & Company upped their target price on shares of Integer from $72.00 to $84.00 and gave the company an “equal weight” rating in a research note on Friday, February 20th. Truist Financial increased their price target on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Friday, February 20th. Piper Sandler reaffirmed an “overweight” rating and set a $97.00 price objective (up from $87.00) on shares of Integer in a report on Friday, May 1st. Finally, Wall Street Zen lowered Integer from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Five research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $100.38.

Integer Stock Performance

NYSE:ITGR opened at $85.15 on Wednesday. The firm’s 50-day moving average is $86.07 and its 200-day moving average is $80.63. The company has a market cap of $2.89 billion, a price-to-earnings ratio of 21.23, a PEG ratio of 1.47 and a beta of 0.67. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75. Integer has a 52-week low of $62.00 and a 52-week high of $123.78.

Integer (NYSE:ITGR) last released its earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a net margin of 7.64% and a return on equity of 12.83%. The company had revenue of $439.58 million during the quarter, compared to the consensus estimate of $426.48 million. During the same quarter in the previous year, the business posted $1.31 EPS. The firm’s quarterly revenue was up .5% on a year-over-year basis. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Equities research analysts anticipate that Integer will post 6.11 earnings per share for the current year.

Insider Buying and Selling at Integer

In other news, VP Tommy P. Thomas sold 825 shares of the stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average price of $85.00, for a total transaction of $70,125.00. Following the sale, the vice president directly owned 4,381 shares of the company’s stock, valued at $372,385. This represents a 15.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.10% of the company’s stock.

Hedge Funds Weigh In On Integer

Large investors have recently bought and sold shares of the business. Salomon & Ludwin LLC boosted its position in shares of Integer by 46.8% in the 4th quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 118 shares during the last quarter. Global Retirement Partners LLC grew its holdings in Integer by 293.8% during the third quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock valued at $33,000 after purchasing an additional 238 shares during the period. TD Private Client Wealth LLC increased its position in shares of Integer by 1,037.5% in the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock valued at $36,000 after buying an additional 415 shares in the last quarter. Parkside Financial Bank & Trust raised its stake in Integer by 135.5% during the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after buying an additional 267 shares during the period. Finally, Arax Advisory Partners raised its stake in Integer by 2,489.5% during the 4th quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 473 shares during the period. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.